Positive phase II data published from GENETIC-AF study of bucindolol in patients with heart failure Aug. 6, 2021
Telix initiates first-in-human study of next-generation prostate cancer therapy candidate TLX-592 Aug. 5, 2021
89Zr-Immuno-PET using bispecific Abeta MAb as promising diagnostic strategy for Alzheimer's disease Aug. 5, 2021
Target engagement, safety seen with anti-TREM-2 monoclonal antibody AL-002 in healthy subjects Aug. 5, 2021
Exosomes conjugated to VEGF antibodies show efficacy in models of choroidal neovascularization Aug. 5, 2021
RSS